Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ME1L
|
|||
| Former ID |
DIB001013
|
|||
| Drug Name |
Digibind
|
|||
| Synonyms |
Digoxin Immune Fab (ovine); Ovine antidigoxin polyclonal antibody fragments (pre-eclampsia), BTG; Ovine antidigoxin polyclonal antibody fragments (pre-eclampsia), GlaxoSmithKline/Glenveigh
Click to Show/Hide
|
|||
| Indication | Eclampsia [ICD-11: JA25; ICD-10: O15] | Phase 2b | [1] | |
| Pre-eclampsia [ICD-11: JA24; ICD-10: O14, O14.9] | Phase 2 | [2] | ||
| Company |
Glenveigh pharmaceuticals
|
|||
| ADReCS Drug ID | BADD_D00669 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010198) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.